SPACInsider Logo
Mana Capital Acquisition Corp. (MAAQ) Shareholders Approve Cardio Diagnostics Deal
by Marlena Haddad on 2022-10-26 at 9:07am

Mana Capital (NASDAQ:MAAQ) announced this morning that its shareholders approved its combination with biopharmaceutical firm Cardio Diagnostics in a special meeting held yesterday.

The press release did not disclose redemption amounts, but MAAQ traded below its trust value of $10 throughout its redemption deadline October 21, and closed yesterday at a low of $5.99.

Nonetheless, the combined company will operate under the name “Cardio Diagnostics Holdings, Inc.,” and will be led by CEO Meeshanthini (Meesha) Dogan, Ph.D., and the rest of its current management team. The company’s common stock and warrants are expected to start trading today on the Nasdaq under the new trading symbols “CDIO” and “CDIOW,” respectively. The warrant exercise price for each Cardio warrant is $11.50.

The parties initially announced their $75 million business combination on May 31. Chicago-based Cardio sells heart health tests direct to consumers via its website and purports to be able to detect whether a patient may experience a heart attack in the near future.

Mana Capital’s stockholders also voted to approve all other proposals presented at the special meeting.


  • The Benchmark Company LLC is serving as the financial advisor to Mana.
  • Becker & Poliakoff LLP is serving as legal advisor to Mana.
  • Shartsis Friese LLP is serving as legal advisor to Cardio Diagnostics.
Recent Posts
by Marlena Haddad on 2023-01-27 at 11:34am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...

by Nicholas Alan Clayton on 2023-01-27 at 10:00am

Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change.  However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...

by Kristi Marvin on 2023-01-27 at 7:33am

Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...

by Nicholas Alan Clayton on 2023-01-27 at 7:30am

In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...

by Marlena Haddad on 2023-01-26 at 5:32pm

Seaport Calibre Materials Acquisition Corp. (Nasdaq: SCMA) announced this afternoon that it is pushing today’s special meeting back until January 31. The SPAC is currently facing a completion deadline of February 1, but is looking to extend its timeline by an additional six months to August 1. Stockholders may elect to redeem their shares for a pro rata...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved